Tue, May 21, 2013, 2:35 PM EDT - U.S. Markets close in 1 hr 25 mins
you are viewing a single comment's thread.
I think antivirals will get the lion's share of the HepC market. Interferon/ribavirin (+ Promcta as needed) will be used in cases of relapsed/refractory HepC pts.
THanks, Long.